Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

The company believes the Food and Drug Administration may deal a setback to one of its investigational therapies.

Biotech stock Alvotech SA (NASDAQ:ALVO) is plummeting to three-year lows, down 29.9% at $5.36 at last check. The FDA declined to approve the company's arthritis drug, sending a list of deficiencies ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Encouraged by the high potato prices during last November’s planting season, Khairul Islam, a farmer from Nabdigonj in Rangpur, invested Tk 10.92 lakh in potato cultivation by borrowing.

Apple recently unveiled new iPad Pros with the latest M5 chipset – those became available last week and are already sporting ...

SPS expects those dynamics to continue in the fourth quarter. The company forecast year-over-year revenue growth of 13% to 14 ...

The extremely concentrated S&P 500 is seeing a growing number of lagging stocks even as it trades near its record high, with ...

Nakamoto Holdings, a public company known for its large bitcoin reserves, has seen its stock collapse by over 98% since May 2025. The decline follows a $563 ...

The Breda-Zappata BZ.308, a sleek Italian four-engine airliner, first flew in 1948. Designed by Filippo Zappata, it blended ...

Sprouts is betting big on a new initiative to try to win over health-conscious shoppers in an increasingly competitive market ...

Sprouts' net sales grew by 13% year over year to $2.2 billion in the third quarter, driven by new store launches and higher ...